Prolium Bioscience

Depleting Disease, Empowering Health

Prolium Bioscience was founded in 2025, is headquartered in New York, United States, lists 1–10 employees, and has $50.0M in recorded funding across 1 round.

Headquarters
New York, New York
Employees
1–10
Founded
2025
Business Model
B2B
Total Funding
$50.0M
Last Round
$50.0M Series AMar 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Prolium Bioscience is a New York City-based clinical-stage biotechnology company developing PRO-203, a potential best-in-class bispecific CD20xCD3 T-cell engager for systemic sclerosis and other severe autoimmune diseases. Founded in 2025 and backed by RTW Investments with a $50M Series A, Prolium targets deep B-cell depletion for durable remissions in refractory autoimmune disease.

Summary

Prolium Bioscience is a Healthcare company based in New York, United States, founded in 2025. It lists 1–10 employees. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Mar 2026. Investors include RTW Investments.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$50.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prolium Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/prolium-bioscience"><img src="https://indexed.vc/api/badge/company/prolium-bioscience" alt="Prolium Bioscience on Indexed.vc" width="260" height="76" /></a>